Article
A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria.
Molecular neurobiology - 1 Nov 2017
de Miranda Aline Silva, Brant Fátima, Vieira Luciene Bruno, Rocha Natália Pessoa, Vieira Érica Leandro Marciano, Rezende Gustavo Henrique Souza, de Oliveira Pimentel Pollyana Maria, Moraes Marcio F D, Ribeiro Fabíola Mara, Ransohoff Richard M, Teixeira Mauro Martins, Machado Fabiana Simão, Rachid Milene Alvarenga, Teixeira Antônio Lúcio
Abstract excerpt
Cerebral malaria (CM) is a life-threatening complication of Plasmodium falciparum infection, which can result in long-term cognitive and behavioral deficits despite successful anti-malarial therapy. Due to the substantial social and economic burden of CM, the development of adjuvant therapies is a scientific goal of highest priority. Apart from vascular and immune responses, changes in glutamate system have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
